Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE: 000766)
China
· Delayed Price · Currency is CNY 15.17
-0.28 (-1.81%)
Jan 3, 2025, 3:04 PM CST
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 43.23 | 43.23 | 30.15 | 35.27 | -359.5 | -2,042 | Upgrade
|
| Depreciation & Amortization | 74.74 | 74.74 | 71.56 | 69.39 | 67.71 | 67.84 | Upgrade
|
| Other Amortization | 0.29 | 0.29 | 0.24 | 0.61 | 1.99 | 2.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.21 | 0.21 | 0.02 | -0.83 | -57.58 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.83 | 1.83 | 0.11 | 0.59 | 0.43 | 2,071 | Upgrade
|
| Loss (Gain) From Sale of Investments | 2.59 | 2.59 | -1.3 | -11.13 | -0.99 | -19.55 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -3.09 | -3.19 | 131.78 | 40.83 | Upgrade
|
| Other Operating Activities | 90.2 | 90.2 | 91.05 | 89.12 | 132.24 | 58.23 | Upgrade
|
| Change in Accounts Receivable | -50.56 | -50.56 | -55.12 | -5.87 | 275.57 | -147.74 | Upgrade
|
| Change in Inventory | 10.18 | 10.18 | 4.12 | 54.74 | -31.63 | 30.86 | Upgrade
|
| Change in Accounts Payable | -60.45 | -60.45 | 58.15 | -116.27 | -61.03 | 26.41 | Upgrade
|
| Operating Cash Flow | 112.78 | 112.78 | 198.16 | 138.33 | 80.71 | 74.86 | Upgrade
|
| Operating Cash Flow Growth | -43.09% | -43.09% | 43.25% | 71.40% | 7.81% | -56.15% | Upgrade
|
| Capital Expenditures | -26.67 | -26.67 | -23.74 | -25.48 | -19.16 | -60.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.33 | 0.33 | 1.59 | 1.01 | 30.28 | 71.02 | Upgrade
|
| Cash Acquisitions | - | - | - | 0.03 | - | - | Upgrade
|
| Divestitures | - | - | - | 16.68 | 1.58 | - | Upgrade
|
| Investment in Securities | - | - | 0.91 | 0.01 | -497.02 | -847.84 | Upgrade
|
| Other Investing Activities | 99.46 | 99.46 | - | 12 | -40.35 | 23.5 | Upgrade
|
| Investing Cash Flow | 73.13 | 73.13 | -21.24 | 4.25 | -524.66 | -814.3 | Upgrade
|
| Long-Term Debt Issued | 130 | 130 | 1,607 | 40 | 1,240 | 1,041 | Upgrade
|
| Long-Term Debt Repaid | -227.2 | -227.2 | -1,662 | -296.9 | -534.75 | -259.17 | Upgrade
|
| Net Debt Issued (Repaid) | -97.2 | -97.2 | -55.33 | -256.9 | 704.85 | 782.19 | Upgrade
|
| Common Dividends Paid | -83.32 | -83.32 | -88.6 | -97.5 | -130.85 | -42.37 | Upgrade
|
| Other Financing Activities | -73.34 | -73.34 | -0.49 | - | 6 | -36.53 | Upgrade
|
| Financing Cash Flow | -253.86 | -253.86 | -144.42 | -354.4 | 580 | 703.29 | Upgrade
|
| Net Cash Flow | -67.95 | -67.95 | 32.5 | -211.82 | 136.04 | -36.15 | Upgrade
|
| Free Cash Flow | 86.11 | 86.11 | 174.42 | 112.85 | 61.55 | 13.88 | Upgrade
|
| Free Cash Flow Growth | -50.63% | -50.63% | 54.56% | 83.35% | 343.45% | -85.59% | Upgrade
|
| Free Cash Flow Margin | 5.84% | 5.84% | 11.86% | 7.45% | 5.54% | 0.70% | Upgrade
|
| Free Cash Flow Per Share | 0.10 | 0.10 | 0.17 | 0.13 | 0.06 | 0.01 | Upgrade
|
| Cash Income Tax Paid | 115.33 | 115.33 | 85.7 | 96.82 | 132.91 | 257.71 | Upgrade
|
| Levered Free Cash Flow | 94.21 | 94.21 | 99.93 | 112.66 | 83.36 | -14.84 | Upgrade
|
| Unlevered Free Cash Flow | 94.21 | 94.21 | 155.42 | 173.41 | 161.65 | 15.65 | Upgrade
|
| Change in Net Working Capital | 43.78 | 43.78 | -27.98 | -58.05 | -327.51 | 20.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.